Gold Stocks With Tailwinds?

Gold Stocks With Tailwinds?

Is it time to consider gold stocks? The price of gold has just moved above its 200-day moving average. Numerous articles are starting to appear declaring …

Read More

AAPL at a Decision Point

AAPL at a Decision Point

In late January, a disappointing earnings report sent Apple (AAPL) down 8%. AAPL has since rebounded almost to the level it was at before the announcement. For …

Read More

Delayed Trades Can Equal Higher Profits

Delayed Trades Can Equal Higher Profits

In a focus on XLB, the SPDRs Materials Sector ETF, in the January 31st, 2014 newsletter, I showed how the ETF was coming off major support, on good volume, and …

Read More

They Are Watching Another Movie

They Are Watching Another Movie

As impressive as the market rebound at the end of last week seemed, the theaters weren't full. Audiences went to some other movie. The Dow Jones Industrial …

Read More

A Six Month Trading Range Falls

A Six Month Trading Range Falls

The homebuilder stocks have been quietly strengthening. Several of them are breaking out of months-long trading ranges, and are pulling their 50-day moving …

Read More

Good News and Bad News

Good News and Bad News

I see good news and bad news. The good news is the recent market pullback is bringing many stocks down off their lofty highs They are taking the time to …

Read More

One Sector Starting to Rebound

One Sector Starting to Rebound

In Monday's newsletter, I showed how the recent pullback, when put into perspective, was both on schedule for a short-term cycle low, and typical in the length …

Read More

Is It Time To Worry?

Is It Time To Worry?

Is last week's action in the markets the sign of something more ominous? Of course there's the possibility a long-overdue more significant pullback may be …

Read More

Not Everyone was Selling

Not Everyone was Selling

Yesterday's market drop once again produced speculation about a market drop, or at least a significant pullback. Most of the Dow's 176 point drop was in the …

Read More

A Medical Stock On a Mission

A Medical Stock On a Mission

In the December 23rd newsletter I referred to my previous articles on Covance relating to how it was a steady stair-stepper stock and has a strong seasonal …

Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.